Gangrene surgery: Difference between revisions
Jump to navigation
Jump to search
Jose Loyola (talk | contribs) No edit summary |
|||
| Line 8: | Line 8: | ||
==Surgery== | ==Surgery== | ||
*The goal of [[surgical treatment]] in [[gangrene]] is to achieve [[revascularization]] to alleviate [[pain]] and avoid [[limb loss]]. | *The goal of [[surgical treatment]] in [[gangrene]] is to achieve [[revascularization]] to alleviate [[pain]] and avoid [[limb loss]]. | ||
*Options to obtain [[revascularation]] include [[intravascular thrombolysis]] using [[catheters]] | *Options to obtain [[revascularation]] include [[intravascular thrombolysis]] using [[catheters]] and [[balloon angioplasty]], with or without the use of [[stents]]. <ref name="pmid25439329">{{cite journal| author=Elsayed S, Clavijo LC| title=Critical limb ischemia. | journal=Cardiol Clin | year= 2015 | volume= 33 | issue= 1 | pages= 37-47 | pmid=25439329 | doi=10.1016/j.ccl.2014.09.008 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25439329 }} </ref> <ref name="pmid27551978">{{cite journal| author=Farber A, Eberhardt RT| title=The Current State of Critical Limb Ischemia: A Systematic Review. | journal=JAMA Surg | year= 2016 | volume= 151 | issue= 11 | pages= 1070-1077 | pmid=27551978 | doi=10.1001/jamasurg.2016.2018 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27551978 }} </ref> | ||
*[[Gas gangrene]] should be [[surgically explored]] and [[debrided]] as soon as possible because it is very aggressive and [[life-threatening]]. If it is done within 24 hours upon admission, chances of survival are high. <ref name="pmid29211672">{{cite journal| author=Stevens DL, Bryant AE| title=Necrotizing Soft-Tissue Infections. | journal=N Engl J Med | year= 2017 | volume= 377 | issue= 23 | pages= 2253-2265 | pmid=29211672 | doi=10.1056/NEJMra1600673 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29211672 }} </ref> | *[[Gas gangrene]] should be [[surgically explored]] and [[debrided]] as soon as possible because it is very aggressive and [[life-threatening]]. If it is done within 24 hours upon admission, chances of survival are high. <ref name="pmid29211672">{{cite journal| author=Stevens DL, Bryant AE| title=Necrotizing Soft-Tissue Infections. | journal=N Engl J Med | year= 2017 | volume= 377 | issue= 23 | pages= 2253-2265 | pmid=29211672 | doi=10.1056/NEJMra1600673 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29211672 }} </ref> | ||
Revision as of 20:45, 27 April 2022
|
Gangrene Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Gangrene surgery On the Web |
|
American Roentgen Ray Society Images of Gangrene surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Edzel Lorraine Co, D.M.D., M.D.
Overview
The goal of surgical treatment in gangrene is to achieve revascularization to alleviate pain and avoid limb loss.
Surgery
- The goal of surgical treatment in gangrene is to achieve revascularization to alleviate pain and avoid limb loss.
- Options to obtain revascularation include intravascular thrombolysis using catheters and balloon angioplasty, with or without the use of stents. [1] [2]
- Gas gangrene should be surgically explored and debrided as soon as possible because it is very aggressive and life-threatening. If it is done within 24 hours upon admission, chances of survival are high. [3]
References
- ↑ Elsayed S, Clavijo LC (2015). "Critical limb ischemia". Cardiol Clin. 33 (1): 37–47. doi:10.1016/j.ccl.2014.09.008. PMID 25439329.
- ↑ Farber A, Eberhardt RT (2016). "The Current State of Critical Limb Ischemia: A Systematic Review". JAMA Surg. 151 (11): 1070–1077. doi:10.1001/jamasurg.2016.2018. PMID 27551978.
- ↑ Stevens DL, Bryant AE (2017). "Necrotizing Soft-Tissue Infections". N Engl J Med. 377 (23): 2253–2265. doi:10.1056/NEJMra1600673. PMID 29211672.